Products - Brain cancers | Topic | NICE

Showing 7 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

DCVax-L for treating glioblastoma [ID836]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Asunercept for treating glioblastoma [ID1301]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
ERC1671 for treating progressed or recurrent grade IV glioma (glioblastoma or gliosarcoma) [ID1623]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Vocimagene amiretrorepvec with extended-release 5-fluorocytosine for treating recurrent high-grade glioma [ID1425]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
MTX110 for untreated diffuse intrinsic pontine glioma [ID2695]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Suspected cancer update
Status:
In development
Expected publication date:
TBC
Tovorafenib for treating relapsed or refractory paediatric low-grade glioma with BRAF fusion or rearrangement or BRAF V600 mutation in people 6 months and over [ID6557]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC